Therapeutic opportunities: Telomere maintenance in inducible pluripotent stem cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 730, Issue 1-2, 2012, Pages 98-105

  Gourronc, Francoise A ^a   Klingelhutz, Aloysius J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

IPS; Pluripotent; Stem cell; Telomerase; Telomere

Indexed keywords

DYSKERIN; HISTONE H4; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

CELL AGING; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CLONING; DNA METHYLATION; DYSKERATOSIS CONGENITA; EMBRYONIC STEM CELL; ENZYME ACTIVATION; FIBROBLAST; GENE MUTATION; HUMAN; INHERITANCE; MALIGNANT TRANSFORMATION; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

ANIMALS; CELL DIFFERENTIATION; DYSKERATOSIS CONGENITA; ENZYME ACTIVATION; EPIGENESIS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NUCLEAR REPROGRAMMING; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS;

IPS; MUS;

EID: 84855487750     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.05.008     Document Type: Review

References (60)

1. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., Miller S.C., Webster C. Plasticity of the differentiated state. Science 1985, 230:758-766.
2. Gurdon J.B., Melton D.A. Nuclear reprogramming in cells. Science 2008, 322:1811-1815.
3. Shiels P.G., Kind A.J., Campbell K.H., Wilmut I., Waddington D., Colman A., Schnieke A.E. Analysis of telomere length in Dolly, a sheep derived by nuclear transfer. Cloning 1999, 1:119-125.
4. Shiels P.G., Kind A.J., Campbell K.H., Waddington D., Wilmut I., Colman A., Schnieke A.E. Analysis of telomere lengths in cloned sheep. Nature 1999, 399:316-317.
5. Lanza R.P., Cibelli J.B., Blackwell C., Cristofalo V.J., Francis M.K., Baerlocher G.M., Mak J., Schertzer M., Chavez E.A., Sawyer N., Lansdorp P.M., West M.D. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 2000, 288:665-669.
6. Schaetzlein S., Rudolph K.L. Telomere length regulation during cloning, embryogenesis and ageing. Reprod. Fertil. Dev. 2005, 17:85-96.
7. Downing G.J., Battey J.F. Technical assessment of the first 20 years of research using mouse embryonic stem cell lines. Stem Cells 2004, 22:1168-1180.
8. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
9. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
10. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
11. Meissner A., Wernig M., Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 2007, 25:1177-1181.
12. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
13. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
14. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
15. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
16. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
17. Kiskinis E., Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 2010, 120:51-59.
18. Banito A., Rashid S.T., Acosta J.C., Li S., Pereira C.F., Geti I., Pinho S., Silva J.C., Azuara V., Walsh M., Vallier L., Gil J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 2009, 23:2134-2139.
19. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
20. Hong H., Takahashi K., Ichisaka T., Aoi T., Kanagawa O., Nakagawa M., Okita K., Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009, 460:1132-1135.
21. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl G.M., Belmonte J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
22. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
23. Marion R.M., Strati K., Li H., Tejera A., Schoeftner S., Ortega S., Serrano M., Blasco M.A. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
24. Yehezkel S., Rebibo-Sabbah A., Segev Y., Tzukerman M., Shaked R., Huber I., Gepstein L., Skorecki K., Selig S. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 2011, 6.
25. Mathew R., Jia W., Sharma A., Zhao Y., Clarke L.E., Cheng X., Wang H., Salli U., Vrana K.E., Robertson G.P., Zhu J., Wang S. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J. 2010, 24:2702-2715.
26. Suhr S.T., Chang E.A., Rodriguez R.M., Wang K., Ross P.J., Beyhan Z., Murthy S., Cibelli J.B. Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One 2009, 4:e8124.
27. Marion R.M., Blasco M.A. Telomere rejuvenation during nuclear reprogramming. Curr. Opin. Genet. Dev. 2010, 20:190-196.
28. Feuerhahn S., Iglesias N., Panza A., Porro A., Lingner J. TERRA biogenesis, turnover and implications for function. FEBS Lett. 2010, 584:3812-3818.
29. Deng Z., Norseen J., Wiedmer A., Riethman H., Lieberman P.M. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol. Cell 2009, 35:403-413.
30. Lister R., Pelizzola M., Kida Y.S., Hawkins R.D., Nery J.R., Hon G., Antosiewicz-Bourget J., O'Malley R., Castanon R., Klugman S., Downes M., Yu R., Stewart R., Ren B., Thomson J.A., Evans R.M., Ecker J.R. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011.
31. Ohi Y., Qin H., Hong C., Blouin L., Polo J.M., Guo T., Qi Z., Downey S.L., Manos P.D., Rossi D.J., Yu J., Hebrok M., Hochedlinger K., Costello J.F., Song J.S., Ramalho-Santos M. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat. Cell Biol. 2011.
32. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., Kim J., Aryee M.J., Ji H., Ehrlich L.I., Yabuuchi A., Takeuchi A., Cunniff K.C., Hongguang H., McKinney-Freeman S., Naveiras O., Yoon T.J., Irizarry R.A., Jung N., Seita J., Hanna J., Murakami P., Jaenisch R., Weissleder R., Orkin S.H., Weissman I.L., Feinberg A.P., Daley G.Q. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
33. Hewitt K.J., Shamis Y., Hayman R.B., Margvelashvili M., Dong S., Carlson M.W., Garlick J.A. Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells. PLoS One 2011, 6:e17128.
34. Liu L., Bailey S.M., Okuka M., Munoz P., Li C., Zhou L., Wu C., Czerwiec E., Sandler L., Seyfang A., Blasco M.A., Keefe D.L. Telomere lengthening early in development. Nat. Cell Biol. 2007, 9:1436-1441.
35. Agarwal S., Loh Y.H., McLoughlin E.M., Huang J., Park I.H., Miller J.D., Huo H., Okuka M., Dos Reis R.M., Loewer S., Ng H.H., Keefe D.L., Goldman F.D., Klingelhutz A.J., Liu L., Daley G.Q. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010, 464:292-296.
36. Kirwan M., Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin. Genet. 2008, 73:103-112.
37. Armanios M., Alder J.K., Parry E.M., Karim B., Strong M.A., Greider C.W. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 2009, 85:823-832.
38. Goldman F., Bouarich R., Kulkarni S., Freeman S., Du H.Y., Harrington L., Mason P.J., Londono-Vallejo A., Bessler M. The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:17119-17124.
39. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., Porteus M.H., Joung J.K., Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009, 5:97-110.
40. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Narva E., Ng S., Sourour M., Hamalainen R., Olsson C., Lundin K., Mikkola M., Trokovic R., Peitz M., Brustle O., Bazett-Jones D.P., Alitalo K., Lahesmaa R., Nagy A., Otonkoski T. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
41. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., Ku S., Martynova M., Semechkin R., Galat V., Gottesfeld J., Izpisua Belmonte J.C., Murry C., Keirstead H.S., Park H.S., Schmidt U., Laslett A.L., Muller F.J., Nievergelt C.M., Shamir R., Loring J.F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
42. Pasi C.E., Dereli-Oz A., Negrini S., Friedli M., Fragola G., Lombardo A., Van Houwe G., Naldini L., Casola S., Testa G., Trono D., Pelicci P.G., Halazonetis T.D. Genomic instability in induced stem cells. Cell Death Differ. 2011, 18:745-753.
43. Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.H., Loh Y.H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Izpisua Belmonte J.C., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011, 471:63-67.
44. Robbins R.D., Prasain N., Maier B.F., Yoder M.C., Mirmira R.G. Inducible pluripotent stem cells: not quite ready for prime time?. Curr. Opin. Organ Transplant. 2010, 15:61-67.
45. Tateishi K., He J., Taranova O., Liang G., D'Alessio A.C., Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 2008, 283:31601-31607.
46. Pfannkuche K., Liang H., Hannes T., Xi J., Fatima A., Nguemo F., Matzkies M., Wernig M., Jaenisch R., Pillekamp F., Halbach M., Schunkert H., Saric T., Hescheler J., Reppel M. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell. Physiol. Biochem. 2009, 24:73-86.
47. Kuzmenkin A., Liang H., Xu G., Pfannkuche K., Eichhorn H., Fatima A., Luo H., Saric T., Wernig M., Jaenisch R., Hescheler J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 2009, 23:4168-4180.
48. Raya A., Rodriguez-Piza I., Aran B., Consiglio A., Barri P.N., Veiga A., Izpisua Belmonte J.C. Generation of cardiomyocytes from new human embryonic stem cell lines derived from poor-quality blastocysts. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:127-135.
49. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., Beard C., Brambrink T., Wu L.C., Townes T.M., Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
50. Raya A., Rodriguez-Piza I., Guenechea G., Vassena R., Navarro S., Barrero M.J., Consiglio A., Castella M., Rio P., Sleep E., Gonzalez F., Tiscornia G., Garreta E., Aasen T., Veiga A., Verma I.M., Surralles J., Bueren J., Izpisua Belmonte J.C. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009, 460:53-59.
51. Taura D., Sone M., Homma K., Oyamada N., Takahashi K., Tamura N., Yamanaka S., Nakao K. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1100-1103.
52. Osakada F., Jin Z.B., Hirami Y., Ikeda H., Danjyo T., Watanabe K., Sasai Y., Takahashi M. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell Sci. 2009, 122:3169-3179.
53. Buchholz D.E., Hikita S.T., Rowland T.J., Friedrich A.M., Hinman C.R., Johnson L.V., Clegg D.O. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009, 27:2427-2434.
54. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
55. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:5856-5861.
56. Sakamoto H., Tsuji-Tamura K., Ogawa M. Hematopoiesis from pluripotent stem cell lines. Int. J. Hematol. 2010, 91:384-391.
57. Ju Z., Jiang H., Jaworski M., Rathinam C., Gompf A., Klein C., Trumpp A., Rudolph K.L. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat. Med. 2007.
58. Calado R.T., Young N.S. Telomere maintenance and human bone marrow failure. Blood 2008, 111:4446-4455.
59. Armanios M. Syndromes of telomere shortening. Annu. Rev. Genomics Hum. Genet. 2009, 10:45-61.
60. Xu D., Alipio Z., Fink L.M., Adcock D.M., Yang J., Ward D.C., Ma Y. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:808-813.